Clinical Implications of Ketosis in Children with Benign Convulsions with Mild Gastroenteritis

Jeong Yong Lee1, Jeong Min Ryu2, Jong Seung Lee2

  • 1Department of Pediatrics, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Insights

Children with convulsions with mild gastroenteritis (CwG) experience significant ketosis. Severe ketosis is linked to lower blood glucose and sodium levels but does not increase seizure recurrence.

Area of Science:

  • Pediatric Neurology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • The underlying causes of benign convulsions with mild gastroenteritis (CwG) in children are not fully understood.
  • Ketosis, a metabolic state, is being investigated for its role in CwG.

Purpose of the Study:

  • To determine the incidence of ketosis in children diagnosed with CwG.
  • To explore the relationship between ketosis and seizure activity in these patients.

Main Methods:

  • A retrospective analysis of pediatric patients (6 months to 6 years) diagnosed with CwG between June 2015 and December 2018.
  • Evaluation of clinical and laboratory data, specifically blood β-hydroxybutyrate levels to define ketosis (≥0.6 mmol/L) and severe ketosis (≥4.5 mmol/L).

Main Results:

  • Ketosis was prevalent in 95.2% of the 42 CwG patients, with 35.7% experiencing severe ketosis.
  • Severe ketosis was associated with lower blood glucose and sodium levels, and a higher proportion of low-body-weight children.
  • No significant difference in the incidence of repetitive seizures was found between severe and non-severe ketosis groups.

Conclusions:

  • Children with CwG exhibit a high degree of ketosis.
  • Severe ketosis in CwG may correlate with hypoglycemia and hyponatremia.
  • Ketosis severity does not appear to influence seizure recurrence in the emergency department setting.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
649
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
189
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
151
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
735
Pathophysiology of Vomiting01:22

Pathophysiology of Vomiting

Vomiting is a complex physiological response to expel harmful or irritating substances from the body. It's a defensive mechanism triggered by stimuli like poisons, microbial toxins, cytotoxic drugs, and mechanical abdominal distension. The process is centrally coordinated by the vomiting (or emetic) center located in the medulla of the brainstem. This area, rich in muscarinic M1, histamine H1, neurokinin 1 (NK1), and serotonin 5-HT3 receptors, coordinates the act of vomiting through...
2.5K